세계의 정형외과용 생체 재료 시장 : 규모, 점유율, 동향 분석(2025-2031년) - MedSuite

Orthopedic Biomaterials Market Size, Share and Trend Analysis | Global | 2025-2031 | MedSuite | Includes: Bone Graft Substitutes Market, Orthopedic Growth Factors Market, and 3 more

US $ 9,995 ￦ 14,183,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 11,995 ￦ 17,022,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄는 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 13,995 ￦ 19,860,000

PDF (Corporate License)

PDF 보고서를 동일 기업(해외)의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄는 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계의 정형외과용 생체 재료 시장 규모는 2024년에 73억 달러에 달했습니다. 이 시장은 4.0%의 CAGR로 확대하며, 2031년에는 96억 달러에 달할 것으로 예측됩니다.

세계 60세 이상 인구는 2020년 10억 명을 돌파하고, 2050년에는 21억 명에 달할 것으로 예측되고 있습니다. 이러한 인구통계학적 변화로 인해 골이식재 및 정형외과용 바이오소재 수요가 증가하고, 특히 노화에 따른 퇴행성 관절염 및 추간판 변성증별 척추 고정술 수요가 증가할 것으로 예상됩니다.

노화 관련 질환의 발생률 증가와 비만도 증가는 정형외과용 바이오소재 및 수복 시술에 대한 수요를 촉진할 것입니다. 척추 고정술 증가는 골이식 대체재 시장을 크게 촉진할 것입니다.

혈소판풍부혈장이나 골수 흡인 농축액과 같은 혁신적인 치료법이 재생의료 분야에서 확대되고 있습니다. 새로운 연골 복구 기술은 환자의 예후를 개선하고 인공관절 치환술의 필요성을 감소시키고 있습니다.

세계의 정형외과용 생체 재료 시장에 대해 조사했으며, 시장의 개요와 부문별 동향, 시장 성장 촉진요인 및 저해요인, 경쟁 시장 점유율 분석 및 시장에 참여하는 기업의 개요 등을 제공하고 있습니다.

목차

개요

조사 방법

제품 평가

• 서론
• 제품 포트폴리오
  • 골이식 대체품
  • 성장 인자
  • 세포치료
  • 히알루론산 관절내 보충 요법(HAV)
  • 연골 수복

  규제 문제와 리콜

  • 골이식 대체품 시장 FDA가 리콜
  • 성장 인자 시장 FDA 리콜

  임상시험

  • 골이식 대체품 시장의 임상시험
  • 성장 인자 시장의 임상시험
  • 세포치료 시장의 임상시험
  • 히알루론산 관절내 보충 요법 시장
  • 연골 수복 시장의 임상시험

세계의 정형외과용 생체 재료 시장 개요

• 서론
• 시장 개요와 동향 분석
  • 부문별
  • 지역별
• 촉진요인과 억제요인
• 경쟁 시장 점유율 분석
• 합병과 인수
• 기업 개요
  • Arthrex
  • Biocomposites
  • Bioventus
  • DePuy Synthes
  • Ferring Pharmaceuticals
  • Fidia Farmaceutici
  • Isto Biologics
  • Harvest Technologies(Terumo)
  • Medtronic
  • Musculoskeletal Transplant Foundation(MTF)
  • Orthofix
  • Sanofi
  • SeaSpine
  • Stryker
  • Vericel
  • Xtant Medical
  • Zimmer Biomet
• SWOT 분석

정형외과용 골이식 대체품 시장

• 개요
• 서론
• 시술 건수
• 시장 개요
• 시장 분석과 예측
• 건수 분석
• 촉진요인과 억제요인
• 경쟁 시장 점유율 분석

정형외과용 성장 인자 시장

• 개요
• 서론
• 시술 건수
• 시장 분석과 예측
• 건수 분석
• 촉진요인과 억제요인
• 경쟁 시장 점유율 분석

정형외과용 세포치료 시장

• 개요
• 서론
• 시술 건수
• 시장 개요
• 시장 분석과 예측
• 건수 분석
• 촉진요인과 억제요인
• 경쟁 시장 점유율 분석

히알루론산 관절내 보충 요법 시장

• 개요
• 서론
• 시술 건수
• 시장 개요
• 시장 분석과 예측
• 촉진요인과 억제요인
• 경쟁 시장 점유율 분석

정형외과용 연골 수복 시장

• 개요
• 서론
• 시술 건수
• 시장 개요
• 시장 분석과 예측
• 촉진요인과 억제요인
• 경쟁 시장 점유율 분석

약어

KSA

영문 목차

영문목차

The global orthopedic biomaterials device market was valued at $7.3 billion in 2024 and is expected to grow at a CAGR of 4.0%, reaching $9.6 billion by 2031.

This market includes multiple key segments:

• Bone Graft Substitute Market (Allograft, Demineralized Bone Matrix (DBM), and Synthetic Bone Grafts)
• Orthopedic Growth Factor Market
• Orthopedic Cell Therapy Market (Bone Marrow Aspirate Concentrate, Platelet-Rich Plasma)
• Hyaluronic Acid (HA) Viscosupplementation Market (Single-, Two-, Three-, and Five-Injection Cycles)
• Orthopedic Cartilage Repair Market (Osteochondral Allograft, Meniscal Allograft, Autologous Chondrocyte Implantation, and Osteochondral Autografts)

Market Insights & Data Coverage

• Unit Sales & Average Selling Prices
• Market Size & Growth Trends
• Procedure Numbers
• Market Drivers & Limiters
• Market Forecasts Until 2031
• Historical Data (2021-2023)
• Competitive Landscape, Mergers & Acquisitions
• Company Profiles & Product Portfolios

Market Trends

Aging Population Driving Market Growth:

• The global population aged 60+ surpassed 1 billion in 2020 and is projected to reach 2.1 billion by 2050.
• This demographic shift is expected to increase the demand for bone grafts and orthopedic biomaterials, especially for spinal fusion procedures due to age-related osteoarthritis and degenerative disc disease.

Growing Incidence of Osteoarthritis & Degenerative Conditions:

• Higher rates of age-related diseases and rising obesity levels will drive demand for orthopedic biomaterials and restorative procedures.
• Increased spinal fusion procedures will significantly boost the market for bone graft substitutes.

Advancements in Cell Therapy & Cartilage Repair:

• Innovative therapies like platelet-rich plasma and bone marrow aspirate concentrates are expanding in regenerative medicine.
• New cartilage repair techniques are improving patient outcomes and reducing the need for total joint replacements.

Market Share Insights

Top Competitors in the Global Orthopedic Biomaterials Market (2024):

1 Medtronic

* Market leader in orthopedic biomaterials, particularly bone graft substitutes and orthopedic growth factors.

* The INFUSE(TM) product line is a dominant player in the orthopedic growth factor market.

2 DePuy Synthes (Johnson & Johnson)

* Second-largest market share, strong presence in bone graft substitutes and HA viscosupplementation.

* Distributes leading HA products MONOVISC(R) and ORTHOVISC(R), manufactured by Anika Therapeutics.

3 Fidia

* Specializes in the HA viscosupplementation market with a five-injection product (HYALGAN(R)) and the first-ever two-injection product (Hymovis(R)) in the U.S.

* TRILURON(R) - A pre-filled HA sodium salt product for knee osteoarthritis treatment.

* The two-injection segment is experiencing rapid growth as lower-injection treatment trends gain traction.

Market Segmentation Summary

• Bone Graft Substitute Market

* Material Type: Allograft, Demineralized Bone Matrix, Synthetic Substitutes

• Orthopedic Growth Factor Market

* Indication Type: Cervical Disc Degeneration, Tibial Fracture, Spine, Ankle & Hindfoot Fusions

• Orthopedic Cell Therapy Market

* Material Type: Platelet-Rich Plasma, Bone Marrow Aspirate Concentrates

• Hyaluronic Acid (HA) Viscosupplementation Market

* Material Type: Single-Injection, Two-Injection, Three-Injection, Five-Injection Cycles

• Orthopedic Cartilage Repair Market

* Treatment Type: Osteochondral Allograft, Meniscal Allograft, Autologous Chondrocyte Implantation, Osteochondral Autografts

Global Research Scope

• Regions Covered:

* North America (U.S., Canada)

* Latin America (Brazil, Mexico, Argentina, Colombia, Chile)

* Western Europe (Germany, France, U.K., Spain, Italy)

* Central & Eastern Europe (Poland, Russia, Turkey, Hungary)

* Middle East (Saudi Arabia, UAE, Israel)

* Asia Pacific (China, Japan, India, South Korea, Australia)

* Africa (South Africa, Egypt, Nigeria, Kenya)

• Base Year: 2024
• Forecast Period: 2025-2031
• Historical Data: 2021-2023

Quantitative Coverage

• Market Size, Market Shares
• Market Forecasts, Growth Rates
• Units Sold, Average Selling Prices
• Procedure Numbers

Qualitative Coverage

• COVID-19 Impact
• Market Growth Trends & Limiters
• Competitive Analysis & SWOT for Top Competitors
• Mergers & Acquisitions
• Company Profiles & Product Portfolios
• FDA Recalls, Disruptive Technologies
• Disease Overviews

Data Sources:

• Primary Interviews with Industry Leaders
• Government Physician Data & Regulatory Data
• Hospital Private Data
• Import & Export Data
• iData Research Internal Database

TABLE OF CONTENT

Executive Summary

Global Orthopedic Biomaterials Device Market Overview

Competitive Analysis

Emerging Markets and Technologies

Market Developments

Market Trends

Procedure Segmentation

Market Segmentation

Regions Included

Key Report Updates

Version History

research methodology

• Step 1: Project Initiation & Team Selection
• Step 2: Prepare Data Systems and Perform Secondary Research
• Step 3: Preparation for Interviews & Questionnaire Design
• Step 4: Performing Primary Research
• Step 5: Research Analysis: Establishing Baseline Estimates
• Step 6: Market Forecast and Analysis
• Step 7: Identify Strategic Opportunities
• Step 8: Final Review and Market Release
• Step 9: Customer Feedback and Market Monitoring

Product Assessment

• 2.1 Introduction
• 2.2 Product Portfolios
  • 2.2.1 Bone Graft Substitute
  • 2.2.2 Growth Factors
    • 2.2.2.1 NELL-1 Bone Biologics
    • 2.2.2.2 INFUSE(R) by Medtronic
    • 2.2.2.3 OsteoAMP(R) by Bioventus Surgical
    • 2.2.2.4 OP-1(TM) by Stryker/Olympus Biotech (Delisted)
    • 2.2.2.5 The Osteogrow Study
    • 2.2.2.6 AUGMENT(R) Bone Graft
    • 2.2.2.7 Amplex(R) Osteobiologic Bone Graft Substitute
    • 2.2.2.8 i-Factor(TM) Peptide Bone Matrix
  • 2.2.3 Cell Therapy
    • 2.2.3.1 Platelet-Rich Plasma
    • 2.2.3.2 Bone Marrow Aspirate Concentrate
  • 2.2.4 Hyaluronic Acid Viscosupplementation (HAV)
  • 2.2.5 Cartilage Repair
• 2.3 Regulatory Issues and Recalls
  • 2.3.1 Bone Graft Substitute Market FDA Recalls
  • 2.3.2 Growth Factor Market FDA Recalls
• 2.4 Clinical Trials
  • 2.4.1 Bone Graft Substitute Market Clinical Trials
  • 2.4.2 Growth Factor Market Clinical Trials
  • 2.4.3 Cell Therapy Market Clinical Trials
  • 2.4.4 Hyaluronic Acid Viscosupplementation Market
  • 2.4.5 Cartilage Repair Market Clinical Trials

Global Orthopedic Biomaterials Device Market Overview

• 3.1 Introduction
• 3.2 Market Overview & Trend Analysis
  • 3.2.1 By Segment
  • 3.2.2 By Region
• 3.3 Drivers and Limiters
  • 3.3.1 Market Drivers
  • 3.3.2 Market Limiters
• 3.4 Competitive Market Share Analysis
• 3.5 Mergers and Acquisitions
• 3.6 Company Profiles
  • 3.6.1 Arthrex
  • 3.6.2 Biocomposites
  • 3.6.3 Bioventus
  • 3.6.4 DePuy Synthes
  • 3.6.5 Ferring Pharmaceuticals
  • 3.6.6 Fidia Farmaceutici
  • 3.6.7 Isto Biologics
  • 3.6.8 Harvest Technologies (Terumo)
  • 3.6.9 Medtronic
  • 3.6.10 Musculoskeletal Transplant Foundation (MTF)
  • 3.6.11 Orthofix
  • 3.6.12 Sanofi
  • 3.6.13 SeaSpine
  • 3.6.14 Stryker
  • 3.6.15 Vericel
  • 3.6.16 Xtant Medical
  • 3.6.17 Zimmer Biomet
• 3.7 SWOT Analysis
  • 3.7.1 Arthrex
  • 3.7.2 Biocomposites
  • 3.7.3 Bioventus
  • 3.7.4 DePuy Synthes
  • 3.7.5 Ferring Pharmaceuticals
  • 3.7.6 Fidia Farmaceutici
  • 3.7.7 Harvest Technologies (Terumo)
  • 3.7.8 Medtronic
  • 3.7.9 Musculoskeletal Transplant Foundation (MTF)
  • 3.7.10 Orthofix
  • 3.7.11 Sanofi
  • 3.7.12 SeaSpine
  • 3.7.13 Stryker
  • 3.7.14 Vericel
  • 3.7.15 Xtant Medical (former Surgalign Holdings)
  • 3.7.16 Zimmer Biomet

Orthopedic Bone Graft Substitute Market

• 4.1 Executive Summary
  • 4.1.1 Global Orthopedic Bone Graft Substitute Market Overview
  • 4.1.2 Competitive Analysis
  • 4.1.3 Regions Included
• 4.2 Introduction
• 4.3 Procedure Numbers
  • 4.3.1 Total Orthopedic Bone Grafting Procedures
  • 4.3.2 Allograft Procedures
  • 4.3.3 Demineralized Bone Matrix Procedures
  • 4.3.4 Synthetic Procedures
• 4.4 Market Overview
  • 4.4.1 By Segment
  • 4.4.2 By Region
• 4.5 Market Analysis and Forecast
  • 4.5.1 Total Orthopedic Bone Graft Substitute Market
  • 4.5.2 Allograft Bone Graft Substitute Market
  • 4.5.3 Demineralized Bone Matrix Allograft Bone Graft Substitute Market
  • 4.5.4 Synthetic Bone Graft Substitute Market
    • 4.5.4.1 Synthetic Bone Graft Substitute Market by Generation Type
• 4.6 Unit Analysis
  • 4.6.1 Allograft Bone Graft Substitute Unit Analysis
    • 4.6.1.1 Allograft Bone Graft Substitute Units Sold by Indication
    • 4.6.1.1.1 Spine Allograft Bone Graft Substitute Units Sold
    • 4.6.1.1.2 Trauma Allograft Bone Graft Substitute Units Sold
    • 4.6.1.1.3 Large Joint Reconstruction Allograft Bone Graft Substitute Units Sold
  • 4.6.2 Demineralized Bone Matrix Allograft Bone Graft Substitute Unit Analysis
    • 4.6.2.1 Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold by Indication
    • 4.6.2.1.1 Spine Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold
    • 4.6.2.1.2 Trauma Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold
    • 4.6.2.1.3 Large Joint Reconstruction Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold
  • 4.6.3 Synthetic Bone Graft Substitute Unit Analysis
    • 4.6.3.1 Synthetic Bone Graft Substitute Units Sold by Indication
    • 4.6.3.1.1 Spine Synthetic Bone Graft Substitute Units Sold
    • 4.6.3.1.2 Trauma Synthetic Bone Graft Substitute Units Sold
    • 4.6.3.1.3 Large Joint Reconstruction Synthetic Bone Graft Substitute Units Sold
• 4.7 Drivers and Limiters
  • 4.7.1 Market Drivers
  • 4.7.2 Market Limiters
• 4.8 Competitive Market Share Analysis

Orthopedic Growth Factor Market

• 5.1 Executive Summary
  • 5.1.1 Global Orthopedic Growth Factor Market Overview
  • 5.1.2 Competitive Analysis
  • 5.1.3 Regions Included
• 5.2 Introduction
• 5.3 Procedure Numbers
• 5.4 Market Analysis and Forecast
• 5.5 Unit Analysis
  • 5.5.1 Cervical Disc Degeneration Growth Factor Units Sold
  • 5.5.1 Tibial Fracture Orthopedic Growth Factor Units Sold
  • 5.5.2 Spine Orthopedic Growth Factor Units Sold
  • 5.5.3 Ankle & Hindfoot Fusion Growth Factor Units Sold
• 5.6 Drivers and Limiters
  • 5.6.1 Market Drivers
  • 5.6.2 Market Limiters
• 5.7 Competitive Market Share Analysis

Orthopedic Cell Therapy Market

• 6.1 Executive Summary
  • 6.1.1 Global Orthopedic Cell Therapy Market Overview
  • 6.1.2 Competitive Analysis
  • 6.1.3 Regions Included
• 6.2 Introduction
  • 6.2.1 Platelet-Rich Plasma
  • 6.2.2 Concentrated Bone Marrow Aspirate
• 6.3 Procedure Numbers
  • 6.3.1 Total Orthopedic Cell Therapy Procedures
  • 6.3.2 Platelet-Rich Plasma Procedures
  • 6.3.3 Bone Marrow Aspirate Concentrate Procedures
• 6.4 Market Overview
  • 6.4.1 By Segment
  • 6.4.2 By Region
• 6.5 Market Analysis and Forecast
  • 6.5.1 Platelet-Rich Plasma Market
  • 6.5.2 Bone Marrow Aspirate Concentrate Market
• 6.6 Unit Analysis
  • 6.6.1 Platelet-Rich Plasma Unit Analysis
    • 6.6.1.1 Platelet-Rich Plasma Units Sold by Indication
  • 6.6.2 Bone Marrow Aspirate Concentrate Unit Analysis
    • 6.6.2.1 Bone Marrow Aspirate Concentrate Units Sold by Indication
• 6.7 Drivers and Limiters
  • 6.7.1 Market Drivers
  • 6.7.2 Market Limiters
• 6.8 Competitive Market Share Analysis

Hyaluronic Acid Viscosupplementation Market

• 7.1 Executive Summary
  • 7.1.1 Global Hyaluronic Acid Viscosupplementation Market Overview
  • 7.1.2 Competitive Analysis
  • 7.1.3 Regions Included
• 7.2 Introduction
  • 7.2.1 Benefits of Viscosupplementation
  • 7.2.2 Synovial Fluid
  • 7.2.3 Product Types
    • 7.2.3.1 Single-Injection Products
    • 7.2.3.2 Two-Injection Cycle Products
    • 7.2.3.3 Three-Injection Cycle Products
    • 7.2.3.4 Three-/Five-Injection Cycle Products
• 7.3 Procedure Numbers
• 7.4 Market Overview
  • 7.4.1 By Segment
  • 7.4.2 By Region
• 7.5 Market Analysis and Forecast
  • 7.5.1 Total Hyaluronic Acid Viscosupplementation Market
  • 7.5.2 Single-Injection Hyaluronic Acid Viscosupplementation Market
  • 7.5.3 Two-Injection Hyaluronic Acid Viscosupplementation Market
  • 7.5.4 Three-Injection Hyaluronic Acid Viscosupplementation Market
  • 7.5.5 Five-Injection Hyaluronic Acid Viscosupplementation Market
• 7.6 Drivers and Limiters
  • 7.6.1 Market Drivers
  • 7.6.2 Market Limiters
• 7.7 Competitive Market Share Analysis

Orthopedic Cartilage Repair Market

• 8.1 Executive Summary
  • 8.1.1 Global Orthopedic Cartilage Repair Market Overview
  • 8.1.2 Regions Included
• 8.2 Introduction
  • 8.2.1 Anatomy
  • 8.2.2 Methods for Cartilage Repair
    • 8.2.2.1 Osteochondral Allograft Transfer
    • 8.2.2.2 Autologous Chondrocyte Implantation
    • 8.2.2.3 Meniscal Allograft Transplantation
    • 8.2.2.4 Osteochondral Autograft
    • 8.2.2.5 Microfracture
    • 8.2.2.6 Microfracture Adjunct
    • 8.2.2.7 Osteoarticular Autograft Transfer System
    • 8.2.2.8 Particulated Juvenile Allograft
• 8.3 Procedure Numbers
  • 8.3.1 Total Orthopedic Cartilage Repair Procedures
  • 8.3.2 Osteochondral Allograft Procedures
  • 8.3.3 Meniscal Allograft Procedures
  • 8.3.4 Autologous Chondrocyte Implantation Procedures
  • 8.3.5 Osteochondral Autograft Procedures
• 8.4 Market Overview
  • 8.4.1 By Segment
  • 8.4.2 By Region
• 8.5 Market Analysis and Forecast
  • 8.5.1 Total Orthopedic Cartilage Repair Market
  • 8.5.2 Osteochondral Allograft Market
  • 8.5.3 Meniscal Allograft Market
  • 8.5.4 Autologous Chondrocyte Implantation Market
  • 8.5.5 Osteochondral Autograft Market
• 8.6 Drivers and Limiters
  • 8.6.1 Market Drivers
  • 8.6.2 Market Limiters
• 8.7 Competitive Market Share Analysis

Abbreviations

관련자료